CAR T-Cell Therapy NewsLatest News On CAR T-Cell Therapy FDA Approves Brentuximab Vedotin for Relapsed or Refractory LBCL in Patients Ineligible for Stem Cell Transplant or CAR T-Cell Therapy2/12/2025 4:04 PM New Perspectives for Personalized Therapy of Brain Tumors2/11/2025 4:32 PM Modifying CUL5 Gene Enhances CAR-T Cell Therapy Against Cancer2/11/2025 4:27 PM Human Technopole Seeks Postdoctoral Researcher in Computational Biology for CAR T-cell Therapy Research1/22/2025 9:41 AM Cancer Researchers Look Back on 2024's Progress and Forward to 202512/23/2024 1:29 PM Oncologists Highlight 2024 Cancer Research Advances and 2025 Predictions12/23/2024 7:21 AM FDA Approves Three New Drugs and Investigates Gene Therapy Safety12/3/2024 10:09 AM The Push For A Universal Blood Cancer Therapy7/11/2024 7:24 AM Comparing Bispecific Antibodies and CAR T-Cell Therapy for Relapsed/Refractory ALL4/15/2024 12:22 PM FDA Approves ide-cel for Adults with Relapsed or Refractory Multiple Myeloma4/8/2024 5:02 PM
